4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000039
Chief Financial Officer sold 1,758 shares at $14.95 ($26,282)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WENTWORTH KORY JAMES Chief Financial Officer | 2024-07-08 | Sale 10b5-1 | −1,758 | $14.95 | $26,282 | 81,412 | D: show line 1 in the form |
| Open-market sales · 1,758 sh · avg $14.95 · $26,282 | |||||||
Loading xslF345X05/wk-form4_1720643672.xml…